Panelists conclude discussions on the COMPARZ trial and explore the efficacy of alternative dosing schedules for sunitinib as a treatment for patients with renal cell carcinoma.
For more from this discussion, visit [ Ссылка ]
Ещё видео!
Panelists conclude discussions on the COMPARZ trial and explore the efficacy of alternative dosing schedules for sunitinib as a treatment for patients with renal cell carcinoma.
For more from this discussion, visit [ Ссылка ]